Safety Toxicology Study of Reassortant Mopeia–Lassa Vaccine in Guinea Pigs

Safety Toxicology Study of Reassortant Mopeia–Lassa Vaccine in Guinea Pigs

(1) Background: Mopeia–Lassa reassortant ML29 virus is an investigational, reassortant virus vaccine for the prevention of Lassa fever caused by Lassa virus (LASV). (2) Methods: The vaccine virus ML29-SF was prepared in Vero cells using a serum-free culture medium under Good Manufacturing Practice....

Full description

Saved in:
Bibliographic Details
Main Authors: Bradley S. Wahle, Peter Pushko, Katie Albanese, Dylan M. Johnson, Irina Tretyakova, Igor S. Lukashevich, Thomas Rudge
Format: Article
Language:English
Published: MDPI AG 2025-05-01
Series:Future Pharmacology
Subjects:
toxicology
GLP
Lassa
vaccine
reassortant
virus
Online Access:https://www.mdpi.com/2673-9879/5/2/26
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items